Screener / SEC EDGAR /CIK 0001306830 /10-K filed Feb 24, 2026, compared with Feb 21, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Materials · Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)

Celanese Corp CE

Compare with peers Embed
The 10-K against last year's

133 changes: 22 added, 24 removed, 85 reworded, 2 quiet changes

10-K Feb 24, 2026 vs Feb 21, 2025

10-K 0001306830-26-000031 (Feb 24, 2026) vs 10-K 0001306830-25-000027 (Feb 21, 2025)

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

131 paragraphs · 9 new · 50 reworded · 2 gone · 10-K Feb 24, 2026 against Feb 21, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 86 · 49% changed Every version of it
We may face increased scrutiny from the investment community, other stakeholders, regulators, and the media related to our sustainability activities, including the goals, targets, aspirations and objectives that we announce, and our methodologies and timelines for pursuing them. If our sustainability practices do not meet regulator, investor or other stakeholder expectations and standards, which continue to evolve and may be conflicting, our reputation, ability to attract or retain employees, and attractiveness as an investment, business partner, or as an acquirer could be negatively impacted, which could in turn adversely impact our business and results of operations. Similarly, our failure or perceived failure to pursue or fulfill our goals, targets, and objectives, to comply with ethical, environmental, or other standards, regulations, or expectations, or to satisfy various reporting standards with respect to these matters, within the timelines that we announce, or at all, could have the same negative impacts, as well as expose us to government enforcement actions and private litigation. Even if we achieve the goals, targets, and objectives we set, we may not realize all of the benefits expected at the time they were established.
Paragraph 32 · 37% changed Every version of it
Failure to develop new products products, product applications, and production technologies, or to implement productivity and cost reduction initiatives successfully, technologies may harm our competitive position.
Paragraph 114 · 36% changed Every version of it
We have undertaken and are continuing to undertake initiatives in all of our business segments to improve productivity and performance and to generate cost savings to support our deleveraging efforts. These initiatives, which may be limited or offset by, among other things, contractual obligations, may not be completed or beneficial or the estimated cost savings from such activities may not be realized.
Paragraph 127 · 35% changed Every version of it
In addition, we rely on our senior management team specifically, therefore our future success depends in part on our ability to retain those members of senior management and to identify and develop talent to succeed senior management. The hiring and retention of key personnel and appropriate senior management succession planning will continue to be important to the successful implementation of our strategies. To help attract, retain, and motivate qualified employees, we use share-based awards and performance-based cash incentive awards. Sustained declines in our stock price or lower stock price performance relative to our competitors have reduced the retention value of our share-based awards, which can impact the competitiveness of our compensation. To the extent our compensation programs are not viewed as competitive, our ability to attract, retain, and motivate employees can be weakened, which could harm our results of operations.
Paragraph 25 · 35% changed Every version of it
In November 2022, we completed the acquisition of the M&M Business Mobility & Materials business ("M&M Business") of DuPont. DuPont de Nemours, Inc. (the "M&M Acquisition"). Since closing, we have actively worked, and continue to actively work, to integrate the M&M Business and its systems into our own and improve the performance of the M&M Business. The benefits of the M&M Acquisition, including the anticipated financial benefits and the synergies and growth opportunities, may not be realized as expected or may not be achieved within the anticipated timeframe, or at all. Since closing we have also worked, and continue to actively work, to integrate the M&M Business and its systems into our own. For example, in February 2024 we incorporated the M&M Business into the new enterprise resource planning ("ERP") system used by the Company. As we work to further integrate technology, information and ERP systems, financial reporting and commercial activities, it is possible that we may encounter unanticipated delays, costs or inefficiencies in connection with our continuing efforts to integrate the M&M Business.
Paragraph 64 · 31% changed Every version of it
We are subject to extensive international, national, state, local and other laws and regulations. Failure to comply with these laws, including antitrust, anticorruption and sanctions laws, rules, regulations or court decisions, could expose us to fines, penalties and other costs. Although we have implemented policies, procedures and employee training designed to promote compliance with these laws, rules, regulations and court decisions, there can be no assurance that our employees and business partners and other third parties acting on our behalf will comply with these laws, rules, regulations and court decisions, which could result in fines, penalties and costs and damage to our business reputation. For example, in July 2020 we announced that we had reached settled a final settlement of $92 million with respect to a European Commission competition law investigation by the European Commission based on involving certain of our subsidiaries and three other companies related to certain past ethylene purchases by certain subsidiaries of the Company. purchases. Shell Chemicals Europe, another group certain Repsol entities represented by Stichting Ethylene Claims ("Stichting"), TotalEnergies, OMV, Borealis, LyondellBasell, and more recently, Stichting, on behalf of corporate claimants, and, most recently, TotalEnergies Petrochemicals & Refining SA Versalis entities, have each filed separate claims for damages with the District Court of Amsterdam against four companies, including the Company, Celanese, arising from those activities. BASF SE has Preliminary hearings have been held in certain of these matters. With respect to the Stichting Repsol claims, a ruling on the initial phase, which phase is related to liability and not monetary damages, could be received in the first quarter of 2026, but we do not expect that such ruling would include a damages award or conclude the matter. BASF, Dow, ExxonMobil, BP, MOL Group and Braskem have filed a similar claim claims against Celanese in the Court of Munich, Germany, and Dow filed a second claim against Celanese and others in the Court of Dortmund, Germany. In sum, 11 new claims were filed against Celanese and other ethylene purchasers in 2025 and early 2026, and we anticipate that new or existing claimants may assert additional claims or seek additional damages associated with the 2020 European Commission settlement. We expect additional hearings will take place and briefings will be filed in 2026. See Note 19 - Commitments and Contingencies in the accompanying consolidated financial statements for further information.
Paragraph 28 · 27% changed Every version of it
At As of December 31, 2024, 2025, the Company has $5.4 $4.2 billion of goodwill and $1.5 $1.2 billion of indefinite-lived intangible assets recorded on its balance sheet. We test goodwill and indefinite-lived intangibles for impairment at least annually and more frequently if the Company believes indicators of impairment exist. The valuation models used to determine the fair value of goodwill or indefinite-lived intangible assets are dependent upon various assumptions and reflect management's best estimates.
Paragraph 122 · 26% changed Every version of it
Our credit ratings are an assessment by rating agencies of our ability to pay our debts when due. Consequently, real or anticipated changes in our credit ratings will generally affect the market value of our securities. These credit ratings may not reflect the potential impact of risks relating to our securities. Agency ratings are not a recommendation to buy, sell or hold any security, and may be revised or withdrawn at any time by the issuing organization. Each agency's rating should be evaluated independently of any other agency's rating. We have in the past been subject to ratings downgrades, and we cannot be assured that we will be able to maintain our current credit ratings, and any additional actual or anticipated negative changes or downgrades in our credit ratings or ratings outlook or watch, including any announcement that our ratings are under review for a downgrade, could further increase our corporate borrowing costs and affect the market value of our securities and may have a negative impact on our liquidity, capital position and access to capital markets.

MD&A

148 paragraphs · 13 new · 75 reworded · 22 gone · 10-K Feb 24, 2026 against Feb 21, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 31 · 48% changed
•lower raw material costs volume in our Engineered Materials and Acetyl Chain segments. segments, primarily driven by weaker global economic conditions and decreased global demand; and
Paragraph 99 · 48% changed
On December 10, 2024, CNC entered into a credit facility agreement (the "CNC Revolving Credit Agreement," together with the CNC Three Year Working Capital Loan Agreement, the CSIT Revolving Credit Agreement, the China Working Capital Term Loan Agreement and the CNC Working Capital Loan Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S. Credit Agreements, the "Global Credit Agreements")) for a CNY1.0 billion uncommitted senior unsecured revolving credit facility (the "CNC December 2024 Facility", and together with the CSIT January 2023 Facility and any other revolving credit facilities available to the Company's subsidiaries in China, the "China Revolving Credit Facilities"). Obligations bear interest at certain floating rates. We expect the China Credit Agreements Facilities will continue to facilitate our efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of our U.S. debt to China at a lower average interest rate.
Paragraph 53 · 48% changed
•a decrease of $133 accelerated depreciation expense of $67 million in capital expenditures during for the year ended December 31, 2024. 2025, primarily related to the 2024 closures of our polymerization units in Uentrop, Germany and our facility in Mechelen, Belgium;
Paragraph 104 · 47% changed
The net proceeds from the 2023 Offering March 2025 Offering, together with borrowings under the November 2024 U.S. Term Loan Credit Facility, were used (i) to fund the March 2025 Tender Offer and Offers, (ii) for the repayment of other outstanding indebtedness. indebtedness, including a portion of the March 2022 U.S. Term Loan Credit Facility, borrowings under the U.S. Revolving Credit Facility and certain senior unsecured notes due March 15, 2025 and (iii) to pay related fees and expenses.
Paragraph 93 · 45% changed
Also in March 2022, we On August 11, 2025, Celanese U.S. entered into a new senior unsecured revolving credit agreement (as amended to date, the (the "U.S. Revolving Credit Agreement" and, Facility" and together with the March 2022 U.S. Term Loan Credit Agreement Facility and the November 2024 U.S. Term Loan Credit Facility, the "U.S. Credit Agreements") Facilities"), consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027. 2030, which replaced the existing U.S. revolving credit facility. The margin for borrowings under the U.S. Revolving Credit Facility is 1.00% to 2.00% (or between 0.00% and 1.00% in the case of U.S. dollar base rate borrowings) above certain interbank rates at current Company credit ratings. The U.S. Revolving Credit Facility had no outstanding balance as of December 31, 2025
Paragraph 85 · 44% changed
•a decrease •an increase of $133 $21 million in capital expenditures during the year ended December 31, 2024. 2025, primarily due to the sale of long-lived assets in our Engineered Materials segment.
Paragraph 78 · 43% changed
Cash and cash equivalents decreased $843 increased $301 million to $962 million $1.3 billion as of December 31, 2024 2025 compared to December 31, 2023. 2024. As of December 31, 2024, $627 2025, $828 million of the $962 million $1.3 billion of cash and cash equivalents was held by our foreign subsidiaries. Under the Tax Cuts Cash and Jobs Act, we have incurred a prior year charge associated with the deemed repatriation of cash equivalents held by foreign earnings. These funds subsidiaries are largely accessible without additional material tax consequences, consequences if needed in the U.S., to fund operations. See Note 15 - Income Taxes in the accompanying consolidated financial statements for further information.
Paragraph 103 · 42% changed
In August 2023, (3)On March 14, 2025, Celanese U.S. completed a public offering of senior unsecured notes registered under the Securities Act as follows (collectively, the "2023 Offering"): in aggregate principal amounts of €750 million and $1.8 billion (the "March 2025 Offering"). On March 21, 2025, Celanese U.S. completed cash tender offers for €552 million and $500 million in aggregate principal amounts of senior unsecured notes (the "March 2025 Tender Offers").

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 8 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

Risk Factors227 words changed in this paragraph; it is 59% similar to last year's version.
We are subject to extensive international, national, state, local and other laws and regulations. Failure to comply with these laws, including antitrust, anticorruption and sanctions laws, rules, regulations or court decisions, could expose us to fines, penalties and other costs. Although we have implemented policies, procedures and employee training designed to promote compliance with these laws, rules, regulations and court decisions, there can be no assurance that our employees and business partners and other third parties acting on our behalf will comply with these laws, rules, regulations and court decisions, which could result in fines, penalties and costs and damage to our business reputation. For example, in July 2020 we announced that we had reached settled a final settlement of $92 million with respect to a European Commission competition law investigation by the European Commission based on involving certain of our subsidiaries and three other companies related to certain past ethylene purchases by certain subsidiaries of the Company. purchases. Shell Chemicals Europe, another group certain Repsol entities represented by Stichting Ethylene Claims ("Stichting"), TotalEnergies, OMV, Borealis, LyondellBasell, and more recently, Stichting, on behalf of corporate claimants, and, most recently, TotalEnergies Petrochemicals & Refining SA Versalis entities, have each filed separate claims for damages with the District Court of Amsterdam against four companies, including the Company, Celanese, arising from those activities. BASF SE has Preliminary hearings have been held in certain of these matters. With respect to the Stichting Repsol claims, a ruling on the initial phase, which phase is related to liability and not monetary damages, could be received in the first quarter of 2026, but we do not expect that such ruling would include a damages award or conclude the matter. BASF, Dow, ExxonMobil, BP, MOL Group and Braskem have filed a similar claim claims against Celanese in the Court of Munich, Germany, and Dow filed a second claim against Celanese and others in the Court of Dortmund, Germany. In sum, 11 new claims were filed against Celanese and other ethylene purchasers in 2025 and early 2026, and we anticipate that new or existing claimants may assert additional claims or seek additional damages associated with the 2020 European Commission settlement. We expect additional hearings will take place and briefings will be filed in 2026. See Note 19 - Commitments and Contingencies in the accompanying consolidated financial statements for further information.

Source: Item 1A, 10-K 0001306830-26-000031 vs Item 1A, 10-K 0001306830-25-000027

Legal Proceedings194 words changed in this paragraph; it is 40% similar to last year's version.
As previously reported, in July 2020, the Company settled a European Commission competition law investigation involving certain of its subsidiaries and three other companies related to certain past ethylene purchases. Shell Chemicals Europe, another group certain Repsol entities represented by Stichting Ethylene Claims ("Stichting"), TotalEnergies, OMV, Borealis, LyondellBasell, and more recently, Stichting, on behalf of corporate claimants, and, most recently, TotalEnergies Petrochemicals & Refining SA Versalis entities, have each filed separate claims for damages with the District Court of Amsterdam against four companies, including Celanese, the Company, arising from those activities. BASF SE has Preliminary hearings have been held in certain of these matters. With respect to the Stichting Repsol claims, a ruling on the initial phase, which phase is related to liability and not monetary damages, could be received in the first quarter of 2026, but the Company does not expect that such ruling would include a damages award or conclude the matter. BASF, Dow, ExxonMobil, BP, MOL Group and Braskem have filed a similar claim claims against the Company in the Court of Munich, Germany. The Company intends to vigorously defend itself Germany, and Dow filed a second claim against these claims. While it is possible that additional parties could assert demands or claims related to this matter, based on information available at this time, the Company does not expect ultimate resolution and others in the Court of this matter to have a material impact on its financial condition or results of operations. Dortmund, Germany. In sum, 11 new claims were filed against the Company and other ethylene

Source: Item 3, via Note 19 – Commitments and Contingencies, 10-K 0001306830-26-000031 vs Item 3, via Note 19 – Commitments and Contingencies, 10-K 0001306830-25-000027

MD&A116 words changed in this paragraph; it is 38% similar to last year's version.
On December 10, 2024, CNC entered into a credit facility agreement (the "CNC Revolving Credit Agreement," together with the CNC Three Year Working Capital Loan Agreement, the CSIT Revolving Credit Agreement, the China Working Capital Term Loan Agreement and the CNC Working Capital Loan Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S. Credit Agreements, the "Global Credit Agreements")) for a CNY1.0 billion uncommitted senior unsecured revolving credit facility (the "CNC December 2024 Facility", and together with the CSIT January 2023 Facility and any other revolving credit facilities available to the Company's subsidiaries in China, the "China Revolving Credit Facilities"). Obligations bear interest at certain floating rates. We expect the China Credit Agreements Facilities will continue to facilitate our efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of our U.S. debt to China at a lower average interest rate.

Source: Item 7, 10-K 0001306830-26-000031 vs Item 7, 10-K 0001306830-25-000027

Accounting Policies101 words changed in this paragraph; it is 51% similar to last year's version.
The Company has exposure to the prices of commodities in its procurement of certain raw materials. The Company manages its exposure to commodity risk primarily through the use of long-term supply agreements, multi-year purchasing and sales agreements and forward purchase contracts. The Company regularly assesses its practice of using forward purchase contracts and other raw material hedging instruments in accordance with changes in economic conditions. Forward purchases and swap contracts for raw materials are principally settled through physical delivery of the commodity. For qualifying contracts, the Company has elected to apply the normal purchases and normal sales exception based on the probability at the inception and throughout the term of the contract that the Company would not net settle and the transaction would result in the physical delivery of the commodity. Accordingly, realized gains and losses on these contracts are included in the cost of the commodity upon the settlement of the contract.

Source: 10-K text, Note 2 – Summary of Accounting Policies, 10-K 0001306830-26-000031 vs 10-K text, Note 2 – Summary of Accounting Policies, 10-K 0001306830-25-000027

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of CE's Risk Factors and MD&A, 10-K Feb 24, 2026 against 10-K Feb 21, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
for loss. Furthermore, in certain cases where we benefit from local government subsidies or other undertakings, such benefits are subject to the solvency of local government entities and are subject to termination without meaningful recourse or remedies.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedRisk Factors
From time to time, we provide guidance regarding our expected financial performance, which may take the foregoing and other factors into account. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and our guidance may not ultimately be accurate. If our guidance varies from actual results, the market value of our common stock could decline significantly.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedRisk Factors
Our increasing reliance on artificial intelligence ("AI") technologies in our products, services, and operations presents risks that could adversely impact our business, financial condition, and results of operations.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedRisk Factors
We are increasingly incorporating AI capabilities into the development of technologies and our business operations, and into our products and services, including, for example, our Chemille platform. AI technology is complex and rapidly evolving, and
Read it in 10-K Feb 24, 2026 at sec.gov
AddedRisk Factors
may subject us to significant competitive, reputational, cybersecurity, legal, regulatory, operational and other risks. If our products and services incorporating AI fail to operate as anticipated or as well as competing offerings or otherwise do not meet customer needs, our business and reputation may be adversely impacted. Our use of AI may introduce operational vulnerabilities by producing inaccurate outcomes or suggestions. Incorporating AI also gives rise to litigation risk and risk of non-compliance and unknown cost of compliance, as AI is an emerging technology for which the legal and regulatory landscape is not fully developed or uniform.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedRisk Factors
Our efforts to develop and use AI responsibly, may not successfully mitigate all associated risks. Any failure to address concerns relating to the responsible use of AI technology may cause harm to our reputation or financial liability and, as such, may increase our costs to address or mitigate such risks and issues.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedRisk Factors
controls, we may not always be able to contractually limit our exposure to third party claims should our failure to perform result in downstream supply disruptions or product recalls.
Read it in 10-K Feb 24, 2026 at sec.gov
Show the other 53
AddedRisk Factors
Due to scheduled step downs of the required consolidated leverage ratio under our U.S. revolving credit facility (the "U.S. Revolving Credit Facility") taking effect beginning in the first quarter of 2026, we believe we may be unable to comply with the consolidated leverage ratio in its current form within the twelve-month period subsequent to the date of this filing unless we are able to implement sufficient mitigation strategies. Such strategies include, but are not limited to, amending the outstanding U.S. Revolving Credit Facility consistent with prior similar amendments we have obtained over the past several years, obtaining a waiver of the default, replacing the U.S. Revolving Credit Facility with a new revolving credit facility, consummating additional divestiture opportunities, and/or reducing operating costs. Implementation of such strategies may increase our borrowing costs under existing material financing arrangements. If we are not able to implement sufficient mitigating strategies and are therefore not able to comply with the consolidated leverage ratio, the lenders under the U.S. Revolving Credit Facility could elect to terminate the facility. As of the date of this filing, the U.S. Revolving Credit Facility has no outstanding borrowings.
Read it in 10-K Feb 24, 2026 at sec.gov
RemovedRisk Factors
impact of incidents, particularly for sophisticated attacks. These factors may inhibit our ability to provide prompt, full, and reliable information about the incident to our customers, partners, regulators, and the public.
Read it in 10-K Feb 21, 2025 at sec.gov
RemovedRisk Factors
formaldehyde under the TSCA. We anticipate that, consistent with the TSCA, the EPA will develop a draft risk management plan that is expected to be released for public comment in approximately 12 months.
Read it in 10-K Feb 21, 2025 at sec.gov
RewordedRisk Factors
Shell Chemicals Europe, another group certain Repsol entities represented by Stichting Ethylene Claims ("Stichting"), TotalEnergies, OMV, Borealis, LyondellBasell, and more recently, Stichting, on behalf of corporate claimants, and, most recently, TotalEnergies Petrochemicals & Refining SA Versalis entities, have each filed separate claims for damages with the District Court of Amsterdam against four companies, including the Company, Celanese, arising from those activities.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
If the potential financial and other benefits and synergies of the M&M Business going forward do not materialize in the amounts or on the timing we expect, or if we are not as successful as we plan at aligning our and the M&M Business's practices and operations, then our business, financial performance and operating results could be adversely affected.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
The intended closure of our facility in Mechelen, Belgium, resulted in charges during fiscal 2024 and Lanaken, Belgium is expected to result in charges charges, including employee termination costs, of $140 million through fiscal 2028. 2027.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
Despite our level of indebtedness, we expect to continue to have the ability to borrow additional debt. debt though there is no guarantee we will be able to borrow on the same terms as our existing indebtedness.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
In During the fourth quarter of three months ended December 31, 2022, we concluded settlement discussions with the Dutch tax authority, and in during the third quarter of three months ended September 30, 2024, we concluded settlement discussions with the German tax authority related to the German transfer pricing audit.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
The Credit Agreements require the maintenance of certain financial ratios and contain other covenants including, but not limited to, restrictions on our and certain of our subsidiaries' ability to incur additional debt; incur liens securing debt; increase dividends, repurchase our Common Stock or make other restricted payments; merge or consolidate with any other person; and sell, assign, transfer, lease, convey or otherwise dispose of all or substantially all of the Issuer's assets or the assets of certain subsidiaries.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
Our operations are also subject to global political conditions, which may be subject to heightened uncertainty as a result of changes in governmental administration in the jurisdictions in which we operate and elsewhere. uncertainty.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
In furtherance of our deleveraging efforts, we have completed our planned divestiture of the Micromax® business, executed a number of transactions to manage our debt maturity profile, paused our share repurchase program and are in the process of evaluating additional cash generation or conservation opportunities.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
We may incur significant charges or experience other significant risks and uncertainties in the event we close or divest all or part of a manufacturing plant or facility and or engage in other divestitures that introduce significant risks and uncertainties. divestitures.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
Physical impacts that could be associated with climate change, such as increased frequency and severity of hurricanes and fires, droughts, hurricanes, floods and impact other weather events and impacts on sea levels, as well as other catastrophic events, may also impact our facilities and operations and those of our key suppliers.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
Failure to develop new products products, product applications, and production technologies, or to implement productivity and cost reduction initiatives successfully, technologies may harm our competitive position.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
Our indebtedness and interest expense, could adversely affect us, decrease our business flexibility, diminish our ability to raise additional capital to fund our operations or refinance our existing indebtedness when it matures, adversely affect our credit ratings, ratings (which may in turn increase our interest expense), and limit our ability to react to changes in the economy or the chemicals industry.
Read it in 10-K Feb 24, 2026 at sec.gov
Quiet changesRisk Factors
The Indentures contain covenants including, but not limited to, restrictions on our and certain of our subsidiaries' ability to incur liens securing debt; merge or consolidate with any other person; and sell, assign, transfer, lease, leaseback, convey or otherwise dispose of certain or all or substantially all of the Issuer's assets or the assets of certain subsidiaries.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
•lower spending of $195 million, primarily as a result of the realization of synergy and cost savings actions in our Engineered Materials and Other Activities segments during the year ended December 31, 2025; and
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
•current year impacts of a non-deductible goodwill impairment loss, recognition of a valuation allowance on U.S. foreign tax credit carryforwards due to revised forecasts of foreign sourced income and expenses during the carryforward period, the further integrated global principal operations and the relocation of certain intangible assets among wholly-owned foreign affiliates and the settlement of tax examinations with German tax authorities; and
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
•a decrease in earnings from our Ibn Sina strategic affiliate, primarily due to lower methyl tertiary-butyl ether ("MTBE") volume arising from weaker economic conditions, as well as lower MTBE pricing and higher feedstock costs.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
•an increase in proceeds from long-term debt, primarily due to $4.0 billion in proceeds received from the March 2025 Offering (defined below) and December 2025 Offering (defined below);
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
Celanese (Nanjing) Chemical Co., Ltd. ("CNCC") has entered into various working capital loans that bear interest at floating interest rates or fixed interest rates and expire on various dates beginning December 2026 through July 2028. These working capital loans have an outstanding balance of $571 million as of December 31, 2025.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
On April 11, 2025, CNCC entered into a CNY100 million revolving credit facility guaranteed by Celanese U.S. (the "CNCC Revolving Credit Facility" and together with the CSIT Revolving Credit Facility, the "China Revolving Credit Facilities") expiring 12 months from the drawdown date. No draws were initiated as of December 31, 2025.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
Due to scheduled step downs of the required consolidated leverage ratio under the U.S. Revolving Credit Facility taking effect beginning in the first quarter of 2026, we believe we may be unable to comply with the consolidated leverage ratio in its current form within the twelve-month period subsequent to the date of this filing unless we are able to implement sufficient mitigation strategies. Such strategies include, but are not limited to, amending the outstanding U.S. Revolving Credit Facility consistent with prior similar amendments we have obtained over the past several years, obtaining a waiver of the default, replacing the U.S. Revolving Credit Facility with a new revolving credit facility, consummating additional divestiture opportunities, and/or reducing operating costs. Implementation of such strategies may increase our borrowing costs under existing material financing arrangements. If we are not able to implement sufficient mitigating strategies and are therefore not able to comply with the consolidated leverage ratio, the lenders under the U.S. Revolving Credit Facility could elect to terminate the facility. As of the date of this filing, the U.S. Revolving Credit Facility has no outstanding borrowings. We currently do not expect to draw on the U.S. Revolving Credit Facility to fund our operations or financial obligations within the twelve-month period subsequent to the date of this filing and expect to have sufficient liquidity available to meet our operational and capital investment needs and financial obligations for the foreseeable future.
Read it in 10-K Feb 24, 2026 at sec.gov
RemovedMD&A
•prior year impacts that did not recur in the current year, including the relocation of certain intangible assets to better align with the acquired M&M foreign operations, the realignment of our European headquarters and principal operations to Switzerland to achieve operational efficiencies, the release of valuation allowances on U.S. foreign tax credit carryforwards, and the excess of the U.S. GAAP gain over the tax gain from the formation of the Nutrinova joint venture; and
Read it in 10-K Feb 21, 2025 at sec.gov
RemovedMD&A
•lower volume, primarily driven by the formation of the Nutrinova joint venture (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information) and reduced demand for elastomers due to weaker automotive demand, partially offset by higher volume for certain products, principally for POM in Europe and Asia;
Read it in 10-K Feb 21, 2025 at sec.gov
RemovedMD&A
•higher spending of $40 million, primarily as a result of increased plant operating and maintenance expenses, including costs at our new acetic acid unit at Clear Lake, Texas, and plant turnaround costs related to our joint venture, Fairway Methanol LLC;
Read it in 10-K Feb 21, 2025 at sec.gov
RemovedMD&A
In September 2023, we formed a food ingredients joint venture with Mitsui & Co., Ltd. ("Mitsui") under the name Nutrinova. We contributed receivables, inventory, property, plant and equipment, certain other assets, liabilities, technology and employees of our food ingredients business while retaining a 30% interest in the joint venture. Mitsui acquired the remaining 70% interest in the food ingredients business for a purchase price of $503 million, subject to transaction adjustments. We accounted for our interest in the joint venture as an equity method investment, and our portion of the results will continue to be included in the Engineered Materials segment. For further information regarding the food ingredients joint venture, see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements.
Read it in 10-K Feb 21, 2025 at sec.gov
RemovedMD&A
We remain in compliance with the covenants in the existing Global Credit Agreements (defined below, and as amended to date) and expect to remain in compliance based on our current expectation of future results of operations and planned cash generation activities. If the actual future results of our operations and cash generation activities differ materially from these expectations, we may be required to seek an amendment to or waiver of any impacted covenants, which may increase our borrowing costs under the existing Global Credit Agreements.
Read it in 10-K Feb 21, 2025 at sec.gov
RemovedMD&A
•a decrease in proceeds of long-term debt, primarily due to the issuance of certain senior unsecured notes of $3.0 billion during the year ended December 31, 2023, that did not recur in the current year, partially offset by current year borrowings on working capital loan facilities in China; and
Read it in 10-K Feb 21, 2025 at sec.gov
RemovedMD&A
Also in January 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn in January 2023 and was fully repaid during the three months ended March 31, 2024.
Read it in 10-K Feb 21, 2025 at sec.gov
RemovedMD&A
In December 2023, Celanese (Nanjing) Chemical Co., Ltd. ("CNC") entered into a senior unsecured working capital loan agreement for CNY800 million, payable on December 25, 2026 and bearing interest at 2.8% (the "CNC Working Capital Loan Agreement"). The loan under the CNC Working Capital Loan Agreement was fully drawn during the three months ended March 31, 2024.
Read it in 10-K Feb 21, 2025 at sec.gov
RewordedMD&A
Year Ended December 31, 2025 2024 2023 Change (In $ millions, except percentages) Statement of Operations Data Net sales 10,280 10,940 (660) 9,544 10,268 (724) Gross profit 2,356 2,603 (247) 1,952 2,336 (384) Selling, general and administrative ("SG&A") expenses (1,030) (1,075) 45 (899) (1,033) 134 Other (charges) gains, net (1,581) (1,744) (68) (1,676) 163 Gain (loss) on disposition of businesses and assets, net (5) (14) 505 (519) 9 Operating profit (loss) (697) 1,687 (2,384) (786) (720) (66) Equity in net earnings (loss) of affiliates 127 196 102 94 (69) Non-operating pension and other postretirement employee benefit (expense) income 55 (20) (69) 49 75 Interest expense (701) (676) (720) 44 (25) Refinancing expense (68) — (68) Interest income 24 33 39 (6) (9) Dividend income - equity investments 122 128 126 2 (6) Earnings (loss) from continuing operations before tax (996) 1,183 (2,179) (1,220) (1,019) (201) Earnings (loss) from continuing operations (1,506) 1,973 (3,479) (1,130) (1,526) 396 Earnings (loss) from discontinued operations (21) (8) (9) 1 (13) Net earnings (loss) (1,514) 1,964 (3,478) (1,151) (1,534) 383 Net earnings (loss) attributable to Celanese Corporation (1,522) 1,960 (3,482) (1,165) (1,542) 377 Other Data Depreciation and amortization 760 801 706 95 (41) SG&A expenses as a percentage of Net sales 10.0 9.4 % 9.8 10.1 % Operating margin(1) (6.8) (8.2) % 15.4 (7.0) % Other (charges) gains, net Restructuring (68) (107) (52) (55) 39 Asset impairments impairment losses (1,513) (1,639) (15) (1,624) 126 Plant/office closures — 2 (1) 3 (2) Total Other (charges) gains, net (1,581) (1,744) (68) (1,676) 163
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Year Ended % December 31, 2025 2024 2023 Change Change (In $ millions, except percentages) Net sales 4,763 4,884 (121) (2.5)% 5,390 5,595 (205) (3.7)% Net Sales Variance Volume 4 (4) % Price (6) (1) % Currency — 1 % Other (charges) gains, net (1,552) (1,724) 172 10.0% Operating profit (loss) 951 1,109 (158) (14.2)% (958) (1,197) 239 20.0% Operating margin 20.0 (17.8) % 22.7 (21.4) % Dividend income - equity investments 127 124 3 2.4% Equity in net earnings (loss) of affiliates 105 172 (67) (39.0)% Depreciation and amortization 244 217 27 12.4% 447 510 (63) (12.4)%
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Year Ended % December 31, 2025 2024 2023 Change Change (In $ millions, except percentages) Net sales 4,232 4,763 4,884 (121) (2.5)% (531) (11.1)% Net Sales Variance Volume 4 (6) % Price (6) % Currency — 1 % Operating profit (loss) 951 1,109 (158) (14.2)% 539 946 (407) (43.0)% Operating margin 20.0 12.7 % 22.7 19.9 % Dividend income - equity investments 121 127 124 3 2.4% (6) (4.7)% Depreciation and amortization 263 244 217 27 12.4% 19 7.8%
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
In Engineered Materials, at our Nanjing, China facility, our expansions of (1) the compounding plant is in construction was completed and we are accelerating completion to meet demand began production activities during the three months ended December 31, 2025 and (2) the new liquid crystal polymer ("LCP") plant is in construction and remains on schedule under a delayed timeline. for completion in the second half of 2026.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
In the accompanying consolidated financial statements, see Note 10 - Current Other Liabilities for current asset retirement obligations, Note 11 - Debt for a description of the guarantees under our Senior Notes and Revolving Credit Agreement, Facility, Note 12 - Benefit Obligations for a description of the pension and other postretirement funding obligations, Note 13 - Environmental for a description of environmental obligations, Note 15 - Income Taxes for a description of uncertain tax positions, Note 16 - Leases for lease obligations and Note 19 - Commitments and Contingencies for a discussion of commitments and contingencies related to legal and regulatory proceedings.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
As of December 31, 2024, 2025, we have $1.75 billion available for borrowing under our senior U.S. unsecured revolving credit facility, $171 million available for borrowing under our separate China Revolving Credit Facilities (defined below) and up to $1.0 billion under the November 2024 U.S.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
We calculated $2.5 billion of all estimate future interest payments on debt and other obligations calculated using the rate interest rates in effect on December 31, 2024 and $493 million of all future pension and other postretirement funding obligations. 2025 to be $3.5 billion.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
In August 2023, (3)On March 14, 2025, Celanese U.S. completed a public offering of senior unsecured notes registered under the Securities Act as follows (collectively, the "2023 Offering"): in aggregate principal amounts of €750 million and $1.8 billion (the "March 2025 Offering").
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
The net proceeds from the 2023 Offering Term Loan Credit Facility, were used (i) to fund the March 2025 Tender Offer and Offers, (ii) for the repayment of other outstanding indebtedness. indebtedness, including a portion of the March 2022 U.S.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
In August 2023, (4)On December 17, 2025, Celanese U.S. completed a public offering of senior unsecured notes registered under the Securities Act as follows (collectively, the "2023 Offering"): in an aggregate principal amount of $1.4 billion (the "December 2025 Offering").
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
(ii) its merger or consolidation with, or transfer of all or substantially all of its assets to, another person; or (iii) its ceasing to be a majority-owned subsidiary of the Issuer in connection with any sale of its capital stock or other transaction.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
For further information regarding the acquisition and related financing transactions, see Debt and Other Obligations in this Liquidity and Capital Resources and See Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information.
Read it in 10-K Feb 24, 2026 at sec.gov
Quiet changesMD&A
In October 2023, we announced the intended closure of our PA66 and certain High-Performance Nylon ("HPN") polymerization units at our facility in Uentrop, Germany to optimize production costs across our global network.
Read it in 10-K Feb 24, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CE/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.